News | News By Subject | News by Disease News By Date | Search News

ALS (Lou Gehrig's disease) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Comeback Kid Cytokinetics (CYTK) Pockets $95 Million Upfront in R&D Deal With Astellas (ALPMY), Needs Results for More     7/27/2016
Iron Horse Therapeutics Launched By Avalon Ventures and GlaxoSmithKline (GSK)     11/10/2015
Biogen (BIIB), the ALS Association and Columbia University Medical Center to Map ALS With Ice Bucket Cash     8/18/2015
How Cytokinetics (CYTK) Will Be Getting Some of That Ice Bucket Challenge Cash     7/15/2015
FDA, Genervon and ALS Blogger Battle Over Clinical Trial Interpretation     4/22/2015
Biogen (BIIB) Drops Idec From Corporate Name, Expands Ambitions in Alzheimer's, ALS     3/24/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Despite Conflicting Data, Cytokinetics, Inc. (CYTK) Plans To Take ALS Drug Into Late Stage Study     10/21/2014
BrainStorm Cell Therapeutics Inc. Nabs FDA Fast-Track Status For ALS Stem Cell Therapy     10/8/2014
Biogen Idec, Inc. (Massachusetts) (BIIB) Poaches Renowned Neurologist From Novartis AG (NVS) To Lead ALS Innovation Hub     8/27/2014
Bay Area's Cytokinetics, Inc. (CYTK) Plummets As ALS Drug Fails Phase 2B Study; Stock Down -64.67% At Market Close (April 25, 2014)     4/28/2014
BrainStorm Cell Therapeutics Inc. Says Stem Cells Helped 75-Year Old Patient With ALS And MG     1/7/2014
Neuraltus Pharmaceuticals, Inc. Seeks $30 Million for New Lou Gehrig's Disease Drug Trial     10/10/2013

News from Around the Web
ALS Patients Communicate for First Time in Years With New Device, PLoS Biology Reveals     2/1/2017
One Gene Predicts Rapid ALS Progression 80 Percent of the Time, Methodist Neurological Institute Study     12/10/2012
Stem Cell Model Offers Clues to Cause of Inherited ALS, University of California, San Diego (UCSD) Study     6/22/2011
Ring Finger Length Linked to ALS, King's College London Study Suggests     5/10/2011
Vitamin E Users Show Lower ALS Risk, Harvard University Study     3/17/2011
Cigarette Smoking May Increase Risk of Muscle-Wasting Disease, Harvard School of Public Health Study     2/15/2011
Blue-green Algae Tested for Treating ALS, University of South Florida Study     12/22/2010
Genetic Variations Linked to ALS Risk, University Of Montreal Study     8/31/2010
Brain Trauma Can Mimic Lou Gehrig's Disease, Veterans Affairs Medical Center and Boston University School of Medicine Study     8/18/2010
Cleveland Clinic Researcher Finds Treatment Eases Involuntary Laughing, Crying Tied to Alzheimer's, MS     4/16/2010
Lithium Shows No Benefit in ALS, Massachusetts General Hospital Study     4/6/2010
Compound Shows Potential For Slowing Progression Of Lou Gehrig's Disease, University of Rochester Medical Center Study     10/20/2009
Novel Human Stem Cell-based Model Of Amyotrophic Lateral Sclerosis Opens Doors For Rapid Drug Screening, Salk Institute for Biological Studies Study     12/5/2008
Neurons Derived From Embryonic Stem Cells Restore Muscle Function After Injury, Dalhousie University Study     11/21/2008
University of Rochester Gene Find Sheds Light On Motor Neuron Diseases Like ALS     10/27/2008

Press Releases
MediciNova, Inc. Announces Exploratory Interim Clinical Outcomes Data From Clinical Trial Of MN-166 (Ibudilast) In ALS Presented At The American Academy of Neurology 69th Annual Meeting In Boston     4/26/2017
Neuraltus Pharmaceuticals, Inc. Release: Retrospective Analysis Finds Amyotrophic Lateral Sclerosis Patients With High Serum C-Reactive Protein (CRP) Levels May Respond To Immune Regulators Like NP001     4/4/2017
Neuraltus Pharmaceuticals, Inc. Provides Enrollment Update On Confirmatory Phase II Study Of NP001 In ALS     2/9/2017
Barrow Neurological Institute Identifies New Genes Responsible For ALS Using IBM Watson Health     12/15/2016
Karyopharm (KPTI) And Collaborators Awarded Grant For ALS Research     12/15/2016
BrainStorm Cell Release: In-Depth Analyses Presented At International Symposium On ALS/MND Suggest Strong Biological Effect For NurOwn; Evidence Of Halting Of Disease Progression     12/14/2016
Cytokinetics (CYTK) Announces New Data Presented At The International Symposium On ALS/MND     12/9/2016
Mitsubishi Tanabe Release: 12-month Edaravone Clinical Study Data In ALS Presented At The 27th International Symposium On ALS/MND     12/9/2016
Origent And Cytokinetics (CYTK) Present Analyses Demonstrating Baseline Data Predict Measures Of Vital Capacity In Patients With ALS     12/7/2016
Towards The Company's First Clinical Trial; Kadimastem Signs Letter Of Intent With Hadassah Medical Center For Performance Of The Clinical Trial In ALS     11/3/2016
PatientsLikeMe Launches Virtual Trial For ALS Patients     10/25/2016
Cytokinetics (CYTK) Announces First Patient Enrolled In VIGOR-ALS, An Open-Label Extension Clinical Trial Of Tirasemtiv     10/18/2016
Synapse Biomedical Release: New ALS Device Trial; The PARADIGM Study Will Continue Research Of The NeuRx Diaphragm Pacing System (DPS) In ALS Patients     10/4/2016
AB Science (AB.PA) Announces The Filing Of Masitinib In The Treatment Of Amyotrophic Lateral Sclerosis (ALS) To The EMA     9/30/2016
FDA Accepts Mitsubishi Tanabe's NDA Filing For Edaravone To Treat ALS     8/30/2016